Is Becker muscular dystrophy eligible for Elevidys? In this article, we’ll explore current research, FDA guidance, and expert insights to answer whether Becker muscular dystrophy is eligible for Elevidys and what this means for future gene therapy advancements.
Does Elevidys Benefit Becker Patients?
No — Based on published literature information, patients with Becker muscular dystrophy (BMD) may not benefit from ELEVIDYS (delandistrogene moxeparvovec‑rokl) gene therapy.
- Follow Us -
Here’s a breakdown of why:
Table of Contents
✅ What ELEVIDYS is approved for
- ELEVIDYS is approved by the U.S. Food & Drug Administration (FDA) only for patients with Duchenne muscular dystrophy (DMD) who are at least 4 years old ambulatory and have a confirmed mutation in the DMD gene. >>> Elevidys Gene Therapy Will Continue to Be Used in Ambulatory DMD Patients
- Verification of clinical benefit may be needed for ELEVIDYS to continue to be approved for non-ambulatory people with Duchenne. Studies are ongoing to assess this potential impact. >>> Elevidys
- The prescribing information states specifically that patients with any deletion in exon 8 and/or exon 9 in the DMD gene are contraindicated for ELEVIDYS. >>> Elevidys
🚫 Why BMD patients not eligible
- BMD is caused by mutations in the same DMD gene but those mutations typically allow some partially functional dystrophin to be produced, leading to a milder form of disease compared to DMD. Read More: Becker Muscular Dystrophy: Symptoms, Causes, and Cures
- According to a statement, the clinical policy document clearly states: “Patients with Becker Muscular Dystrophy (BMD) are unlikely to benefit from ELEVIDYS gene therapy.” (Molina Healthcare… Read This)
- The therapy was developed for the more severe deficiency in DMD, not for the partially functioning situation in BMD.
📋 Summary
- Eligible: DMD, age ≥ 4 yrs and ambulatory, confirmed DMD gene mutation, excluding certain deletions (exon 8/9).
- Not eligible: Patients with BMD (because of different disease mechanism/severity) and those with certain DMD gene deletions (exon 8/9).
- If you have Becker, ELEVIDYS is not indicated under current approval/coverage.
Learn More: Frequently Asked Questions About Elevidys
- Follow Us -
